Top Markets
Coin of the day
Guangdong Taiantang Pharmaceutical Co., Ltd. Guangdong Taiantang Pharmaceutical Co., Ltd.

Guangdong Taiantang Pharmaceutical Co., Ltd.

002433
Rank in Stocks #27878
Guangdong Taiantang Pharmaceutical Co., Ltd. operates within China,... Guangdong Taiantang Pharmaceutical Co., Ltd. operates within China, specializing in the entire lifecycle of traditional Chinese patent medicines, from initial research and development to manufacturing and distribution. Their diverse product portfolio encompasses various dosage forms, including topical creams and ointments, oral tablets, capsules, pills, and liquid solutions. These pharmaceutical products cater to a wide array of therapeutic areas, such as reproductive and dermatological health, cardiovascular and cerebrovascular conditions, and anti-inflammatory treatments, among others. Additionally, the company is actively involved in the acquisition, cultivation, processing, and sale of raw Chinese medicinal materials. Founded in 1995, its corporate headquarters are situated in Shantou, China.
Share Price
$0.03912675
Last synced: 2024-07-04
Market Cap
$30.00M
Change (1 day)
-5.19%
Change (1 year)
0.00%
Country
CN
Trade Guangdong Taiantang Pharmaceutical Co., Ltd. (002433)

Category

P/E ratio for Guangdong Taiantang Pharmaceutical Co., Ltd. (002433)
P/E ratio as of 2026 TTM: 0
According to Guangdong Taiantang Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Guangdong Taiantang Pharmaceutical Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.